JP Morgan Upgrades Corteva to Overweight, Lowers Price Target to $19
JP Morgan analyst Jeffrey Zekauskas upgrades Corteva (NYSE:CTVA) from Neutral to Overweight and lowers the price target from $83 to $19.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga